✦ LIBER ✦

An open-label study to evaluate the efficacy of retreatment of patients with psoriasis who have previously been treated with etanercept

Book ID: 116587234
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 41 KB
Volume: 64
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2010.09.166

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label, single-arm, phase 2 study

An open-label, single-arm, phase 2 study of single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who have been previously treated with bortezomib

✍ Ravi Vij; David S. Siegel; Sundar Jagannath; Andrzej J. Jakubowiak; Alexander Ke 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with plaque psoriasis who have shown an unsatisfactory response to etanercept

✍ Robert Bissonnette; Chantal Bolduc; Yves Poulin; Lyn Guenther; Charles W. Lynde; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 414 KB

The efficacy and safety of infliximab in

The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study

✍ Gottlieb, Alice B.; Kalb, Robert E.; Blauvelt, Andrew; Heffernan, Michael P.; So 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 430 KB

Combination therapy with etanercept and

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

✍ Mark C. Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Ric 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

## Abstract ## Objective To determine the potential for additive or synergistic effects of combination therapy with the selective anti–tumor necrosis factor α agent etanercept and the anti–interleukin‐1 agent anakinra. ## Methods Two hundred forty‐four patients in whom rheumatoid arthritis (RA)

An open label pilot study to evaluate th

An open label pilot study to evaluate the efficacy of lymphoblastoid interferon (L-IFN) in patient with chronic hepatitis C previously treated with recombinant alpha-interferon (R-IFN)

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Retreatment of gefitinib in patients wit

Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: A single-arm, open-label, phase II study

✍ Oh, In-Jae; Ban, Hee-Jung; Kim, Kyu-Sik; Kim, Young-Chul 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 497 KB